Citadel Advisors
MRNY icon

Citadel Advisors’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Citadel Advisors’s Portfolio MRNY Stock Details MRNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,880
Closed -$33.3K – 13570
2025
Q3 		$33.3K Buy
1,880
+800
+74% +$16.6K ﹤0.01% 12372
2025
Q2 		$25.4K Buy
1,080
+540
+100% +$13.3K ﹤0.01% 12048
2025
Q1 		$14.9K Buy
+540
New +$20.7K ﹤0.01% 13343

Other funds holding MRNY

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
MCA
McGuire Capital Advisors Bethany, Oklahoma $156M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's MRNY Position: Q1 2026 in Review

Citadel Advisors sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026, closing a stake of 16,712 shares — an estimated $246K sold.

Citadel Advisors first reported a position in MRNY in Q2 2025 and held it in 3 quarters. The position peaked at $246K in Q4 2025. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

  • Citadel Advisors reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 16,712 YieldMax MRNA Option Income Strategy ETF shares in Q1 2026, an estimated $246K.
  • Citadel Advisors first reported a position in YieldMax MRNA Option Income Strategy ETF in Q2 2025 and held it in 3 quarters.
  • Citadel Advisors's YieldMax MRNA Option Income Strategy ETF position peaked at $246K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.